View in EDS HTML Full Text PDF Full Text

A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.

Saved in:
Bibliographic Details
Title: A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
Authors: Yan M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Yuan P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ouyang Q; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China., Cheng Y; Department of Oncology, Cancer Hospital of Jilin Province, Changchun, China., Han G; Department of Breast Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, China., Wang D; Department of Thoracic Surgery, Hainan General Hospital, Haikou, China., Ran L; Department of Oncology, The Affiliated Hospital of Guizhou Medical University/Guizhou Cancer Hospital, Guiyang, China., Sun T; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China., Zhao D; Department of Internal Medicine-Oncology, The First Hospital of Lanzhou University, Lanzhou, China., Bai Y; Department of Oncology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China., Yang S; Department of Breast Cancer and Lymphoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China., Wang X; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital and Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China., Wu R; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China., Zeng X; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China., Yao H; Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Ji X; Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China., Jiang J; Department of Surgical Oncology, General Hospital of Mining Industry Group Fuxin, Fuxin, China., Hu X; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lin H; Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China., Zheng L; Department of Breast-Thoracic Tumor Surgery, Affiliated Hospital of Hainan Medical University, Haikou, China., Zhu Z; Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China., Ge W; Center of Oncology, Renmin Hospital of Wuhan University, Wuhan, China., Yang J; Department of Medical Oncology, People's Liberation Army General Hospital, Beijing, China., Cui T; Department of Oncology, Fujian Provincial Hospital, Fuzhou, China., Zhang X; Department of Radiotherapy and Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Lu F; Department of Oncology, The Second Affiliated Hospital of Guiyang Medical University, Guiyang, China., Li W; Department of Radiotherapy, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical College, Kunming, China., Xu H; Department of Oncology, Jilin Second People's Hospital, Jilin, China., Kang M; Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, Guilin, China., Gong P; Department of Oncology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China., Zou L; Department of Oncology, West China Hospital, Sichuan University, Chengdu, China., Liu J; Department of Oncology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China., Zhang H; Department of Oncology, Xinjiang Uygur Autonomous Region Chinese Medicine Hospital, Urumqi, China., Yu H; School of Public Health, Nanjing Medical University, Nanjing, China., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, No.17 Panjiayuannanli, Chaoyang District, Beijing 100021, China.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Oct 24; Vol. 14, pp. 17588359221122715. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36330235
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yan+M%22">Yan M</searchLink>; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Yuan+P%22">Yuan P</searchLink>; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ouyang+Q%22">Ouyang Q</searchLink>; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Cheng+Y%22">Cheng Y</searchLink>; Department of Oncology, Cancer Hospital of Jilin Province, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Han+G%22">Han G</searchLink>; Department of Breast Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, China.<br /><searchLink fieldCode="AU" term="%22Wang+D%22">Wang D</searchLink>; Department of Thoracic Surgery, Hainan General Hospital, Haikou, China.<br /><searchLink fieldCode="AU" term="%22Ran+L%22">Ran L</searchLink>; Department of Oncology, The Affiliated Hospital of Guizhou Medical University/Guizhou Cancer Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Sun+T%22">Sun T</searchLink>; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Zhao+D%22">Zhao D</searchLink>; Department of Internal Medicine-Oncology, The First Hospital of Lanzhou University, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Bai+Y%22">Bai Y</searchLink>; Department of Oncology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Department of Breast Cancer and Lymphoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital and Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+R%22">Wu R</searchLink>; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Zeng+X%22">Zeng X</searchLink>; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Yao+H%22">Yao H</searchLink>; Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Ji+X%22">Ji X</searchLink>; Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.<br /><searchLink fieldCode="AU" term="%22Jiang+J%22">Jiang J</searchLink>; Department of Surgical Oncology, General Hospital of Mining Industry Group Fuxin, Fuxin, China.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Lin+H%22">Lin H</searchLink>; Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.<br /><searchLink fieldCode="AU" term="%22Zheng+L%22">Zheng L</searchLink>; Department of Breast-Thoracic Tumor Surgery, Affiliated Hospital of Hainan Medical University, Haikou, China.<br /><searchLink fieldCode="AU" term="%22Zhu+Z%22">Zhu Z</searchLink>; Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.<br /><searchLink fieldCode="AU" term="%22Ge+W%22">Ge W</searchLink>; Center of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Medical Oncology, People's Liberation Army General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cui+T%22">Cui T</searchLink>; Department of Oncology, Fujian Provincial Hospital, Fuzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Radiotherapy and Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Lu+F%22">Lu F</searchLink>; Department of Oncology, The Second Affiliated Hospital of Guiyang Medical University, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Radiotherapy, Tumor Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical College, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Oncology, Jilin Second People's Hospital, Jilin, China.<br /><searchLink fieldCode="AU" term="%22Kang+M%22">Kang M</searchLink>; Department of Medical Oncology, The Affiliated Hospital of Guilin Medical University, Guilin, China.<br /><searchLink fieldCode="AU" term="%22Gong+P%22">Gong P</searchLink>; Department of Oncology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.<br /><searchLink fieldCode="AU" term="%22Zou+L%22">Zou L</searchLink>; Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Department of Oncology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Department of Oncology, Xinjiang Uygur Autonomous Region Chinese Medicine Hospital, Urumqi, China.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; School of Public Health, Nanjing Medical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Xu+B%22">Xu B</searchLink>; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, No.17 Panjiayuannanli, Chaoyang District, Beijing 100021, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2022 Oct 24; Vol. 14, pp. 17588359221122715. <i>Date of Electronic Publication: </i>2022 Oct 24 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36330235
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359221122715
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359221122715
    Titles:
      – TitleFull: A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yan M
      – PersonEntity:
          Name:
            NameFull: Yuan P
      – PersonEntity:
          Name:
            NameFull: Ouyang Q
      – PersonEntity:
          Name:
            NameFull: Cheng Y
      – PersonEntity:
          Name:
            NameFull: Han G
      – PersonEntity:
          Name:
            NameFull: Wang D
      – PersonEntity:
          Name:
            NameFull: Ran L
      – PersonEntity:
          Name:
            NameFull: Sun T
      – PersonEntity:
          Name:
            NameFull: Zhao D
      – PersonEntity:
          Name:
            NameFull: Bai Y
      – PersonEntity:
          Name:
            NameFull: Yang S
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Wu R
      – PersonEntity:
          Name:
            NameFull: Zeng X
      – PersonEntity:
          Name:
            NameFull: Yao H
      – PersonEntity:
          Name:
            NameFull: Ji X
      – PersonEntity:
          Name:
            NameFull: Jiang J
      – PersonEntity:
          Name:
            NameFull: Hu X
      – PersonEntity:
          Name:
            NameFull: Lin H
      – PersonEntity:
          Name:
            NameFull: Zheng L
      – PersonEntity:
          Name:
            NameFull: Zhu Z
      – PersonEntity:
          Name:
            NameFull: Ge W
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Cui T
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Lu F
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Xu H
      – PersonEntity:
          Name:
            NameFull: Kang M
      – PersonEntity:
          Name:
            NameFull: Gong P
      – PersonEntity:
          Name:
            NameFull: Zou L
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Yu H
      – PersonEntity:
          Name:
            NameFull: Xu B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 10
              Text: 2022 Oct 24
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1